Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth
Lian Zhang,1 Yingying Tong,1 Xiuli Zhang,1 Minggui Pan,2,3 Siyu Chen1 1Department of Oncology, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 2Department of Oncology and Hematology, Kaiser Permanente Medical Center, S...
Main Authors: | Zhang L, Tong Y, Zhang X, Pan M, Chen S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-10-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | https://www.dovepress.com/arsenic-sulfide-combined-with-jq1-chemotherapy-agents-or-celecoxib-inh-peer-reviewed-article-DDDT |
Similar Items
-
Arsenic sulfide amplifies JQ1 toxicity via mitochondrial pathway in gastric and colon cancer cells
by: Tan Z, et al.
Published: (2018-11-01) -
Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivo
by: Zhang L, et al.
Published: (2015-10-01) -
Combination effects of nobiletin and celecoxib on the growth inhibition of colon cancer cells
by: Ya-Chi Sun, et al.
Published: (2011) -
Arsenic sulfide induces miR-4665-3p to inhibit gastric cancer cell invasion and migration
by: Zhang X, et al.
Published: (2019-08-01) -
In Memoriam: JQ Johnson
by: Sarah Shreeves
Published: (2012-09-01)